Navigation Links
CORD:USE Cord Blood Bank Congratulates Team Member Hal Broxmeyer, Ph.D., on his Election as President of the American Society of Hematology
Date:1/28/2010

ORLANDO, Fla., Jan. 28 /PRNewswire/ -- CORD:USE Cord Blood Bank congratulates CORD:USE team member and highly esteemed advisor Hal Broxmeyer, Ph.D., on becoming the 2010 President of the American Society of Hematology ("ASH").

"Being elected as President of such an important organization as ASH is a tremendous achievement and a testament to the pioneering research and body of work that Dr. Broxmeyer has performed, and we are deeply honored to have him as an integral member of our team," said CORD:USE President and CEO Edward Guindi, M.D.  

The American Society of Hematology is the world's largest professional society, with more than 16,000 members from 97 countries, concerned with the causes and treatments of blood disorders.  The mission of the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.

Dr. Broxmeyer is internationally recognized as a founder of the field of umbilical cord blood stem cell transplantation.  He helped start the first cord blood banking company and was involved in planning and coordinating the first successful cord blood transplant performed in 1988.  He set up the first proof-of-principal cord blood bank, which supplied the first five cord blood collections for HLA-matched sibling cord blood transplants.  As a result of the research of Dr. Broxmeyer and his colleagues, cord blood has been used in transplantation therapy for more than 16,000 patients with over 70 life-threatening diseases, such as leukemia, lymphoma, thalassemia, and sickle cell anemia.  

Dr. Broxmeyer is the Chairman of the Department of Microbiology and Immunology, former Director of the Walther Oncology Center and Mary Margaret Walther Professor Emeritus, Distinguished Professor of the Indiana University School of Medicine.  He is a member of the Cord Blood Committee of the National Marrow Donor Program ("NMDP") and has been a member of the Health Resources and Services Administration's ("HRSA") Advisory Council on Blood Stem Cell Transplantation.  In his more than 30 year career, he has authored over 600 publications and has served as an editor on many peer reviewed journals.  Dr. Broxmeyer has won numerous awards, including the highly prestigious E. Donnall Thomas Prize from ASH.  

About CORD:USE Cord Blood Bank

CORD:USE Cord Blood Bank, headquartered in Orlando, Florida, is creating a large, ethnically diverse, high quality inventory of available cord blood stem cell units for the many patients in need of a potentially life-saving transplant.  CORD:USE has assembled a team of world leaders in the field of cord blood banking and transplantation.  CORD:USE has entered into agreements with hospitals across the country to provide mothers the option to donate their babies' cord blood.  CORD:USE makes these cord blood units available to transplanters throughout the country and around the world, as a critical component in their patients' treatment.  CORD:USE is accredited by the Foundation for the Accreditation of Cellular Therapy ("FACT") and lists all of its units on the National Marrow Donor Program's Registry.  CORD:USE has also been selected by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health as one of the high quality cord blood banks to build the federally supported National Cord Blood Inventory.  For more information, please visit www.corduse.com.

SOURCE CORD:USE Cord Blood Bank

RELATED LINKS
http://www.corduse.com

'/>"/>

SOURCE CORD:USE Cord Blood Bank
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
4. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
5. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
6. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
7. BioMosaics Glypican-3 Blood & Tissue Tests Receive CE Marking in Europe
8. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in Miami
9. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
10. Microlifes Home Blood Pressure Monitors Proven Accurate Even for Critical Patients
11. WaveSense Blood Glucose Meter One of Few Brands to Pass Rigorous TNO Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is ... vendors and unique items from across the nation, this holiday-themed event will raise funds ... by the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
Breaking Medicine News(10 mins):